Open access
Sep 2026
Efficacy and safety of tofacitinib in polymyalgia rheumatica: a retrospective comparative study.
Tofacitinib-containing regimens were associated with improvement in PMR disease activity, and combination treatment was associated with lower prednisone exposure, support further prospective evaluation of tofacitinib as a potential glucocorticoid-sparing strategy in PMR.
X. Wang, D. Feng, L. Jia et al.
· Scandinavian Journal of Rheu... · 0 citations